ArticleNPJ vaccines2022

Predicted effectiveness of vaccines and extended half-life monoclonal antibodies against RSV hospitalizations in children.

Zhe Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.